1,2,4-trihydroxyanthraquinone Be

Known as: 1,2,4-trihydroxyanthraquinone Be(2+), THAQ-Be(2+) 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2016
012319932016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Mitochondria play a pivotal role in apoptosis: permeabilization of the outer mitochondrial membrane and the release of pro… (More)
Is this relevant?
2016
2016
Purpose The redox milieu, together with reactive oxygen species (ROS) accumulation, may play a role in mediating some biological… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2016
2016
microRNA (miR/miRNA) are small non-coding RNAs that control gene expression at the post-transcriptional level by targeting mRNAs… (More)
Is this relevant?
2014
2014
Neuroblastoma is the most common extracranial solid tumor in children. Approximately half of the affected patients are diagnosed… (More)
Is this relevant?
2005
2005
We have carried out an in vitro study to investigate the ability of substance P to activate cell growth and the NK1 receptor… (More)
Is this relevant?
2005
2005
The insulin-mediated Ras/mitogen-activated protein (MAP) kinase cascade was examined in SK-N-BE(2) and PC12 cells, which can and… (More)
Is this relevant?
1996
1996
We report that upon muscarinic stimulation of SK-N-BE(2) human neuroblastoma cells, the extent of phosphoinositide-derived… (More)
Is this relevant?
1995
1995
Tamoxifen is a commonly used chemotherapeutic agent in human breast cancer, although some tumours develop resistance… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
During development, mice with mutations of stem cell factor (SCF) or its receptor c-kit exhibit defects in melanogenesis, as well… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1994
1994
Administration of myo-[3H]inositol to SK-N-BE(2) human neuroblastoma cells for 24 hr resulted in equilibrium labelling of… (More)
Is this relevant?